Reply to F. Dayyani et al

Affiliations

¹ Pashtoon M. Kasi, MD, MS, Weill Cornell Medicine, Meyer Cancer Center, Englander Institute of Precision Medicine, New York-Presbyterian Hospital, New York, NY; Gordon Fehringer, PhD and Alexey Aleshin, MD, Natera Inc, Austin, TX; and Scott Kopetz, MD, PhD, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Comment

Pashtoon M Kasi et al. JCO Precis Oncol. 2022 Jul.

. 2022 Jul:6:e2200275.

doi: 10.1200/PO.22.00275.

¹ Pashtoon M. Kasi, MD, MS, Weill Cornell Medicine, Meyer Cancer Center, Englander Institute of Precision Medicine, New York-Presbyterian Hospital, New York, NY; Gordon Fehringer, PhD and Alexey Aleshin, MD, Natera Inc, Austin, TX; and Scott Kopetz, MD, PhD, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

No abstract available

Comment on

Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.
Kasi PM, Fehringer G, Taniguchi H, Starling N, Nakamura Y, Kotani D, Powles T, Li BT, Pusztai L, Aushev VN, Kalashnikova E, Sharma S, Malhotra M, Demko ZP, Aleshin A, Rodriguez A, Billings PR, Grothey A, Taieb J, Cunningham D, Yoshino T, Kopetz S. Kasi PM, et al. JCO Precis Oncol. 2022 Mar;6:e2100181. doi: 10.1200/PO.21.00181. JCO Precis Oncol. 2022. PMID: 35263168 Free PMC article. Review.
Spontaneous Fluctuations of Tumor-Informed Circulating Tumor DNA at Low Levels.
Dayyani F, Senthil M. Dayyani F, et al. JCO Precis Oncol. 2022 Jul;6:e2200177. doi: 10.1200/PO.22.00177. JCO Precis Oncol. 2022. PMID: 35834756 No abstract available.